A
Arantza Campo
Researcher at University of Navarra
Publications - 29
Citations - 1606
Arantza Campo is an academic researcher from University of Navarra. The author has contributed to research in topics: Lung cancer & COPD. The author has an hindex of 16, co-authored 28 publications receiving 1395 citations. Previous affiliations of Arantza Campo include Carlos III Health Institute & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest.
Juan P. de Torres,Gorka Bastarrika,Juan P. Wisnivesky,Ana B. Alcaide,Arantza Campo,Luis M. Seijo,Jesus Pueyo,Alberto Villanueva,Maria D. Lozano,Usua Montes,Luis M. Montuenga,Javier J. Zulueta +11 more
TL;DR: Results suggest that the presence of emphysema on low-radiation-dose CT of the chest is an independent risk factor for lung cancer.
Journal ArticleDOI
Early Lung Cancer Detection Using Spiral Computed Tomography and Positron Emission Tomography
Gorka Bastarrika,María José García-Velloso,Maria D. Lozano,Usua Montes,W. Torre,Natalia Spiteri,Arantza Campo,Luis M. Seijo,Ana B. Alcaide,Jesus Pueyo,David A. Cano,Isabel Vivas,Octavio Cosín,Pablo Dominguez,Patricia Serra,José A. Richter,Luis M. Montuenga,Javier J. Zulueta +17 more
TL;DR: A protocol for early lung cancer detection using spiral CT and FDG-PET is useful and may minimize unnecessary invasive procedures for benign lesions.
Journal ArticleDOI
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension
Arantza Campo,S.C. Mathai,J. Le Pavec,Ari L. Zaiman,Laura K. Hummers,Danielle Boyce,Traci Housten,Noah Lechtzin,Hala El Chami,Reda E. Girgis,Paul M. Hassoun +10 more
TL;DR: Hyponatraemia and low systolic blood pressure upon admission and underlying CTD are the main prognostic factors for in-hospital mortality in patients with PAH admitted for RHF, and the short-term outcomes after discharge are poor and remarkably worse in Patients with underlyingCTD or renal impairment.
Journal ArticleDOI
Comparing algorithms for automated vessel segmentation in computed tomography scans of the lung: the VESSEL12 study
Rina D. Rudyanto,Sjoerd Kerkstra,Eva M. van Rikxoort,Catalin Fetita,Pierre Yves Brillet,Christophe Lefevre,Wenzhe Xue,Xiangjun Zhu,Jianming Liang,Ilkay Oksuz,Devrim Unay,Kamuran A. Kadipasaoglu,Raúl San José Estépar,James C. Ross,George R. Washko,Juan Carlos Prieto,Marcela Hernández Hoyos,Maciej Orkisz,Hans Meine,Markus Hüllebrand,Christina Stöcker,Fernando L opez Mir,Valery Naranjo,Eliseo Villanueva,Marius Staring,Changyan Xiao,Berend C. Stoel,Anna Fabijańska,Erik Smistad,Anne C. Elster,Frank Lindseth,Amir Hossein Foruzan,Ryan Kiros,Karteek Popuri,Dana Cobzas,Daniel Jimenez-Carretero,Andres Santos,Maria J. Ledesma-Carbayo,Michael Helmberger,Martin Urschler,Michael Pienn,Dennis Bosboom,Arantza Campo,Mathias Prokop,Pim A. de Jong,Carlos Ortiz-de-Solorzano,Arrate Muñoz-Barrutia,Bram van Ginneken +47 more
TL;DR: An annotated reference dataset is presented and a quantitative scoring system is proposed for objective comparison of algorithms and performance analysis of the strengths and weaknesses of the various vessel segmentation methods in the presence of various lung diseases.
Journal ArticleDOI
Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients
Arantza Campo,Gema Frühbeck,Javier J. Zulueta,Jorge Iriarte,Luis M. Seijo,Ana B. Alcaide,J B Galdiz,Javier Salvador +7 more
TL;DR: Data suggest the extension of leptin resistance to the respiratory centre is extended, associated with a reduction in respiratory drive and hypercapnic response, irrespective of the amount of body fat.